Traveling into the unknown: challenges and opportunities for 21st Century Translational Medicine

Speakers
  • Professor of Immunology and Pediatrics, UMC Utrecht
    Biography
      Berent Prakken is a professor of immunology and pediatrics at the Utrecht Medical Center Utrecht as well as chair of Research and Education of the Wilhelmina Children's Hospital. He heads a translational research lab that focuses on regulation of inflammation and biomarker development in human inflammatory diseases. Prakken published over 170 articles (H index 37) in international journals, including Nature Medicine, Lancet, PNAS, J Exp Med, Immunity, JCI and various Nature Review journals. He and his group received numerous prestigious national and international awards and grants. The Prakken lab hosted a core facility for the Immune Tolerance Network of the NIH, and is an international expertise center for biomarkers and the Luminex technology. Prakken serves as an editor and associate editor of several journals and is a regular reviewer for most major journals in his field. Berent Prakken's personal commitment is to collaboration, societal relevance and training & education. Unconventional thinking and crossing traditional boundaries inspired him and his co-founders to set up the Eureka Institute for Translational Medicine.

    Abstract:

    Translational medicine has been fairly unsuccessful in translating innovation from the lab towards the clinics and back again. Many reasons account for the failure leading to a massive waste in life science research and the steep rise in costs of drug development and a failing pipeline from academia towards industry. The development of biomarkers suffers from similar problems. Despite all high hopes of advances such gene sequencing and multiplex technologies, translation from ‘big data’ into tangible therapies has been fairly unsuccessful with a few notable exceptions. Therefore, in order to truly advance translational medicine we need to examine carefully the root causes of the current problems and set out a completely new course, based on a paradigm shift in thinking about the way we collaborate and perform translational medicine.


    Show Resources
    You May Also Like
    SEP 05, 2019 4:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 4:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    OCT 02, 2019 11:00 AM PDT
    OCT 02, 2019 11:00 AM PDT
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    OCT 31, 2019 9:00 AM PDT
    C.E. CREDITS
    OCT 31, 2019 9:00 AM PDT
    DATE: October 31, 2019TIME: 9:00am PDT, 12:00pm EDT INTRODUCTION: A major limitation for the development of 3D engineered tissues is the absence of viable and perfusable...
    DEC 05, 2019 5:00 AM PST
    C.E. CREDITS
    DEC 05, 2019 5:00 AM PST
    DATE: December 5, 2019TIME: 5:00am PST, 8:00am EST The diagnosis of an active infection by the hepatitis B virus (HBV) relies on testing for the HBV surface antigen (HBsAg). Ov...
    NOV 21, 2019 9:00 AM PST
    C.E. CREDITS
    NOV 21, 2019 9:00 AM PST
    DATE: November 21, 2019TIME: 9:00am PST, 12:00pm EST Multiple Myeloma is a disease of terminally differentiated plasma cells with the massive production of monoclonal immunoglobu...
    Loading Comments...
    Show Resources
    Event Countdown
    • 0 Days
    • 0 Hours
    • 0 Minutes
    • 0 Seconds